THEMISMED - Themis Medicare

Themis Medicare

THEMISMED · Pharma > Pharmaceuticals & Drugs · Chairman: Hoshang N Sinor · MD: Sachin D Patel · Listing date: April 2, 2007 · Employees: 976 · Mumbai · http://www.themismedicare.com

Stock Price vs Company Growth

0.5%

7.3%

4.7%

7.0%

15.0%

1.3%

0.9%

10y

7.5%

all

11.9%

🤔 How to analyze this graph?

Last Traded Price

₹ 105 0.5%

97.3

138

Company Overview

Sales

332 Cr

Growth: -6.8%

Profit after Tax

-53 Cr

Growth: -4735.1%

Small Cap

965 Cr

P/E: 24.2x

Industry P/E: 31.7x

Fundamentals

Sales (Cr)	₹ 332
Growth	-6.8%
EBITDA	-12.6%
P/S	2.9x
Dividend	0.5%
P/E	24.2x
Book Value	₹ 32.3
PEG Ratio	-3.5x
ROE	-15.4%
P/B	3.3x

Shareholding Pattern

Institutions

Anuj Anantrai Sheth

4.89 %

Zafar Ahmadullah

1.76 %

Za Capital Services India Private Ltd

1.29 %

Iepf

0.34 %

Promoters

Vividhmargi Investments Private Ltd.

15.8 %

Gedeon Richter Investment Management Ltd.

9.62 %

Dinesh Shantilal Patel

9.49 %

Vividh Distributors Private Ltd.

7.79 %

Jayshree D Patel

7.26 %

Others

Increase Decrease No change

Company Profile Detailed

Themis Medicare (TML) incorporated in 1969, is engaged in manufacturing of Active Pharmaceutical Ingredients (APIs) and Formulations. Erstwhile known as Themis Chemical the company is promoted by Mr. Shantibhai D. Patel. It is joint venture with Gedeon Richter, Hungary.Headquartered in Mumbai, the company has four manufacturing facilities located at Vapi (Gujarat), Hyderabad (Andhra Pradesh), and Haridwar (Uttaranchal).

Belongs to (4 Indices)

Investors (51)

zafar.ah...

avantika...

iifl.sec...

Followers (2)

vinodgow...

tejasdod...